CTM
Castellum, Inc.
CTM trails on the overall score without a compensating advantage in the available component scores.
MU
Micron Technology, Inc.
MU has the edge over CTM overall, supported by stronger valuation and stronger fundamentals.
CTM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Weak |
CTM's revenue and cash flow are currently stable, but its profitability and balance sheet are under pressure.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
CTM PE Valuation
CTM has no meaningful PE right now: it lost money over the past year.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
CTM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Stable | |
| -- | |
| Limited | |
| High |
Analysts expect CTM's earnings to decline, with its revenue and profitability holding steady.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
CTM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.02 | — |
| Q3 2026 | -$0.04 | +$0.02 |
| Q2 2026 | -$0.03 | +$0.05 |
| Q1 2026 | -$0.02 | +$0.09 |
| Q4 2025 | -$0.03 | +$0.15 |
| Q3 2025 | -$0.06 | +$0.12 |
| Q2 2025 | -$0.08 | +$0.27 |
| Q1 2025 | -$0.11 | +$0.25 |
| Q4 2024 | -$0.18 | +$0.20 |
CTM is still losing money, but far less than before: $0.04 per share over the past year, against $0.58 at its worst in mid-2022.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over CTM on earnings quality, reporting a profit while its opponent remains loss making.
CTM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $14.7M | +0.6% |
| Q2 2026 | $13.9M | -1.1% |
| Q1 2026 | $14.3M | +23% |
| Q4 2025 | $12.6M | +22% |
| Q3 2025 | $14.6M | +26% |
| Q2 2025 | $14M | +22% |
| Q1 2025 | $11.7M | +2.9% |
| Q4 2024 | $10.3M | -7.1% |
CTM's revenue is growing: $15M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -3.8% | -6.9 points |
| Q2 2026 | -7.9% | -5.2 points |
| Q1 2026 | -4.9% | +7.9 points |
| Q4 2025 | -11% | +4.7 points |
| Q3 2025 | 3% | +15 points |
| Q2 2025 | -2.7% | +11 points |
| Q1 2025 | -13% | +11 points |
| Q4 2024 | -16% | -1.9 points |
CTM's operating margin was −3.8% last quarter, down 6.9 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over CTM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over CTM on profitability, with a higher operating margin.
CTM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.3M | -234% |
| Q1 2026 | $1.3M | +$3.8M |
| Q4 2025 | -$671.5K | -$277.1K |
| Q3 2025 | $957K | +30% |
| Q1 2025 | -$2.5M | -10647% |
| Q4 2024 | -$394.4K | -145% |
| Q3 2024 | $738.9K | +$2M |
| Q2 2024 | $748.6K | +33% |
CTM's free cash flow has turned positive again: $366,940 over the past year, against −$1M the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over CTM on cash generation, producing positive trailing cash flow while its opponent burns cash.
CTM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2021 | 29.1x | High |
| Q1 2021 | 11.1x | High |
CTM's net debt is more than 20 years of its operating earnings (EBITDA).
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
CTM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.2 | Neutral |
| Stochastic | 14.3 | Oversold |
CTM's weekly RSI is 36 (neutral) and its Stochastic is 14 (oversold).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
CTM PE vs Technology Sector
CTM has no meaningful PE right now: it lost money over the past year.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU is trading at 11x earnings, a 61% discount to the Technology sector's median of 28x.
CTM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.54 | 17% below |
| 20 week MA | $0.60 | 25% below |
| 50 week MA | $0.74 | 39% below |
| 100 week MA | $0.91 | 51% below |
| 200 week MA | $0.67 | 33% below |
CTM is in a downtrend: it's below all five of its weekly moving averages, and 33% below its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has the edge over CTM on trend strength, trading above more of its moving averages.
CTM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $1.47 | $1.22 | -17% |
| 2023 | $1.22 | $0.30 | -75% |
| 2024 | $0.30 | $1.42 | +373% |
| 2025 | $1.42 | $1.03 | -27% |
| 2026 YTD | $1.03 | $0.45 | -56% |
CTM's yearly returns have swung widely, from +373% in 2024 to −75% in 2023. It's down 56% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over CTM on returns for 2026, with the stronger performance.